» Articles » PMID: 29251175

The Role of S100A4 Protein in Anticancer Cytotoxicity: Its Presence is Required on the Surface of CDCDPGRPsS100A4 Lymphocyte and Undesirable on the Surface of Target Cells

Overview
Journal Cell Cycle
Specialty Cell Biology
Date 2017 Dec 19
PMID 29251175
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

S100A4 is a Ca-binding protein that performs an important role in metastasis. It is also known for its antitumor functions. S100A4 is expressed by a specialized subset of CDCD lymphocytes and is present on those cell's membranes along with peptidoglycan recognition proteins (PGRPs). There, by interacting with major heat shock protein Hsp70, S100A4 plays an important cytotoxic role. The resulting stably formed complex of PGRPs, S100A4 and Hsp70 is required for the identification and binding between a lymphocyte and a target cell. Here, we investigated the S100A4 functions in CDCDPGRPsS100A4 lymphocyte cytotoxicity against target cells. We demonstrated that those lymphocytes do not form a stable complex with the tumor target cells that themselves have S1004A on their surface. That observation can be explained by our finding that S100A4 precludes the formation of a stable complex between PGRPs, S100A4 (on the lymphocytes' surface), and Hsp70 (on the target cells' surface). The decrease in S100A4 level in CDCDPGRPsS100A4 lymphocytes inhibits their cytotoxic activity, while the addition of S100A4 in the medium restores it. Thus, the resistance of target cells to CDCDPGRPs S100A4 lymphocyte cytotoxicity depends on their S100A4 expression level and can be countered by S100A4 antibodies.

Citing Articles

S100A4 exerts robust mucosal adjuvant activity for co-administered antigens in mice.

Sen Chaudhuri A, Yeh Y, Zewdie O, Li N, Sun J, Jin T Mucosal Immunol. 2022; 15(5):1028-1039.

PMID: 35729204 PMC: 9212208. DOI: 10.1038/s41385-022-00535-6.

References
1.
Cajone F, Debiasi S, Parker C, Lakshmi M, Sherbet G . Metastasis-associated mts1 gene expression is down-regulated by heat shock in variant cell lines of the B16 murine melanoma. Melanoma Res. 1994; 4(3):143-50. DOI: 10.1097/00008390-199406000-00001. View

2.
Weaver B . How Taxol/paclitaxel kills cancer cells. Mol Biol Cell. 2014; 25(18):2677-81. PMC: 4161504. DOI: 10.1091/mbc.E14-04-0916. View

3.
Taylor S, Herrington S, Prime W, Rudland P, Barraclough R . S100A4 (p9Ka) protein in colon carcinoma and liver metastases: association with carcinoma cells and T-lymphocytes. Br J Cancer. 2002; 86(3):409-16. PMC: 2375203. DOI: 10.1038/sj.bjc.6600071. View

4.
Chuang L, Lotzova E, Heath J, Cook K, Munkarah A, Morris M . Alteration of lymphocyte microtubule assembly, cytotoxicity, and activation by the anticancer drug taxol. Cancer Res. 1994; 54(5):1286-91. View

5.
Dukhanina E, Yashin D, Galkin A, Sashchenko L . Unexpected deeds of familiar proteins: Interplay of Hsp70, PGRP-S/Tag7 and S100A4/Mts1 in host vs. cancer combat. Cell Cycle. 2010; 9(4):676-82. DOI: 10.4161/cc.9.4.10782. View